Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Generate Capital Raises over $1 Billion to Expand Infrastructure Credit Solutions
-
Cummins Reports Strong Third Quarter Operating Results, Records Non-Cash Charges Related to its Electrolyzer Business
-
Alpha Announces Third Quarter 2025 Financial Results
-
Danaos Corporation Announces Date for the Release of Third Quarter 2025 Results, Conference Call and Webcast
-
Nova Reports Record Third Quarter 2025 Financial Results
-
SelectQuote, Inc. Reports First Quarter of Fiscal Year 2026 Results
-
Tradeweb Reports October 2025 Total Trading Volume of $65.4 Trillion and Average Daily Volume of $2.8 Trillion
-
Continuum Recovery Center of Colorado Selects the Janus Contingency Management Platform to Strengthen Addiction Treatment Services
-
NUBURU Strengthens Balance Sheet, Advances Defense-Tech Acquisition Program and Revamps Blue-Laser Business
-
Neurogene Announces First Participant Dosed in Embolden™ Registrational Trial of NGN-401 Gene Therapy for Rett Syndrome
-
Inspira Enterprise Recognized as a Leader in the Cybersecurity Services for Mid-Market Enterprises PEAK Matrix® Assessment 2025 by Everest Group
-
NETSCOUT Reports Second Quarter Fiscal Year 2026 Financial Results
-
Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025
-
Thailand showcases 'Senses of Siam: A Journey to Total Well-being' at WTM 2025
-
Cars.com Reports Third Quarter 2025 Results
-
Rein Therapeutics Announces New Scientific Publication Demonstrating LTI-03 May Reduce Lung Scarring and Protect Cells Needed for Lung Repair in IPF
-
NextNav Inc. Reports Third Quarter 2025 Results and Operational Highlights
-
CME Group Declares Quarterly Dividend
-
Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025
-
Plus Therapeutics Highlights ReSPECT-LM Clinical Trial Results at 40th SITC Annual Meeting, Melanoma Research Foundation Brain Metastases Summit 4.0
-
Madison Square Garden Entertainment Corp. Reports Fiscal 2026 First Quarter Results
-
FDA approval of CAPLYTA® (lumateperone) has the potential to reset treatment expectations, offering hope for remission in adults with major depressive disorder
-
BIOVECTRA and Revolution Biomanufacturing Partner to Deliver Integrated mRNA Design and GMP Production Services
-
Parker Reports Fiscal 2026 First Quarter Results
-
Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Cronos Group Reports 2025 Third Quarter Results
-
Solo Brands, Inc. Announces Third Quarter 2025 Results
-
MasterCraft Boat Holdings, Inc. Reports Fiscal 2026 First Quarter Results
-
nCino Expands Offering with Eastern Bank to Deliver Connected Lending Experience Across Product Lines
-
Cognition Therapeutics Reports Financial Results for the Third Quarter 2025 and Highlights Progress Across Clinical Programs
-
MACOM Reports Fiscal Fourth Quarter and Fiscal Year 2025 Financial Results
-
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
-
Black Diamond Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Nasdaq Halts Robot Consulting Co., Ltd.
-
SkyWater Technology and QuamCore Announce Collaboration to Advance Scalable Superconducting Quantum Computing
-
Bread Financial to Participate in the KBW Fintech Payments Conference
-
Evaxion announces business update and third quarter 2025 financial results
-
EDAP Reports Third Quarter 2025 Financial Results
-
MavriX Bio Announces First Patient Dosed in ASCEND-AS Trial of MVX-220, Investigational Gene Therapy for Angelman Syndrome
-
PAN GLOBAL DEFINES NEW HIGH-PRIORITY VMS TARGET AT RECENTLY AWARDED ESCACENA SOUTH
-
Callan Publishes Asset Manager Sustainable Investment Practices Study
-
OUTDOOR BRANDS, LLC AND MEYER DISTRIBUTING INC. FINALIZE SALE OF SURELOCK SECURITY CO.
-
Eilean Therapeutics to Present First-in-Class, Wild-Type-Sparing JAK2-JH2/V617F Inhibitor ZE74-0282 at ASH 2025 and Initiate Clinical Studies in December 2025
-
Exodus Movement, Inc. October 2025 Treasury Update and Monthly Metrics
-
Mutuum Finance (MUTM) Confirms Q4 2025 V1 Launch as Phase 6 Nears Completion With Over 18,000 Holders
-
ATDev Joins $41 Million ARPA-H Initiative to Build the Future of Robotic Mobility and Independence
-
From insights to impact, Leinster Rugby leverages data strategy to level up fan experience
-
Briarwood Capital Partners LP Exceeds a 10% Holding in Tecsys Inc.
-
Gradient Launches Parallax, a Sovereign AI Operating System for an Open-Source Future

